(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TARGETED MEDICAL PHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

TARGETED MEDICAL PHARMA

ST13

US500000090107008

Class

35

Filing

90107008

Registration

6459420

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

16

Latest update

08/24/2021

Trademark type

Combined

Nice classes

35

Filing date

08/11/2020

Registration date

08/24/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

08/24/2021

Last transaction

08/24/2021

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

10/04/2006

First use in commerce

10/04/2006

Drawing code

3

Owner type

03

Owner location

Los Angeles, CA

Examiner

ERVIN, INGA

Law office

M20

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the wording "TARGETED MEDICAL PHARMA" within the band of two concentric circles, with the caduceus symbol appearing in the center of the circles. Color is not claimed as a feature of the mark.

Holders and representatives

Holders

Targeted Medical Pharma, Inc.

Representatives

Targeted Medical Pharma, Inc.

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Wholesale distributorships featuring dietary supplements and medical foods

Publications

History of USPTO decisions and trademark events.

16 publications found

R.PR

REGISTERED-PRINCIPAL REGISTER

08/24/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/08/2021

PUBO

PUBLISHED FOR OPPOSITION

06/08/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/19/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/04/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/23/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/23/2021

ALIE

ASSIGNED TO LIE

03/18/2021

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/16/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/09/2020

GNRT

NON-FINAL ACTION E-MAILED

12/09/2020

CNRT

NON-FINAL ACTION WRITTEN

12/09/2020

DOCK

ASSIGNED TO EXAMINER

12/04/2020

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/15/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/13/2020

NWAP

NEW APPLICATION ENTERED

08/14/2020

Continuous trademark protection

Get notified about every new filing that threatens TARGETED MEDICAL PHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.